ANTIBODY-DRUG COMPLEX

An antibody-drug complex represented by formula (I): (in the formula, Ab is an antibody, X is a group represented by formula (X-1), formula (X-2), or formula (X-3): (in the formulas, AA on the left represents a binding site with NH, BB on the right represents a binding site with D.), D is a group represented by formula (D-1) or formula (D-2): (in the formulas, CC represents a binding site with X.), and n ranges from about 1 to about 8.)..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 29. Feb. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

MIYANO MASAYUKI [VerfasserIn]
NAKAZAWA YUYA [VerfasserIn]
ISO KENTARO [VerfasserIn]
YABE YUKI [VerfasserIn]
UMIHARA HIROTATSU [VerfasserIn]
TAGUCHI JUNICHI [VerfasserIn]
INOUE SATOSHI [VerfasserIn]
TSUKAMOTO SHUNTARO [VerfasserIn]
KOGAI HIROYUKI [VerfasserIn]
YAMAGUCHI ATSUMI [VerfasserIn]
AKAGI TSUYOSHI [VerfasserIn]
MUKAI YOHEI [VerfasserIn]
HIRAYAMA TOSHIFUMI [VerfasserIn]
KATO MASAKI [VerfasserIn]
MOCHIZUKI TOSHIKI [VerfasserIn]
YAMAMOTO AKIHIKO [VerfasserIn]
YAMAMOTO YUJI [VerfasserIn]
SAKURADA TAKATO [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-02-29, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09

Patentnummer:

WO2024043319

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA00128035X